首页> 外文期刊>Oncogenesis. >The oncogenic role of the cochaperone Sgt1
【24h】

The oncogenic role of the cochaperone Sgt1

机译:伴侣蛋白Sgt1的致癌作用

获取原文
           

摘要

Sgt1/Sugt1, a cochaperone of Hsp90, is involved in several cellular activities including Cullin E3 ubiqutin ligase activity. The high level of Sgt1 expression in colorectal and gastric tumors suggests that Sgt1 is involved in tumorigenesis. Here, we report that Sgt1 is overexpressed in colon, breast and lung tumor tissues and in Ewing sarcoma and rhabdomyosarcoma xenografts. We also found that Sgt1 heterozygous knockout resulted in suppressed Hras-mediated transformation in vitro and tumor formation in p53 ?/? mouse embryonic fibroblast cells and significantly increased survival of p53 ?/? mice. Moreover, depletion of Sgt1 inhibited the growth of Ewing sarcoma and rhabdomyosarcoma cells and destabilized EWS-FLI1 and PAX3-FOXO1 oncogenic fusion proteins, respectively, which are required for cellular growth. Our results suggest that Sgt1 contributes to cancer development by stabilizing oncoproteins and that Sgt1 is a potential therapeutic target.
机译:Sgt1 / Sugt1是Hsp90的伴侣分子,参与多种细胞活动,包括Cullin E3泛素连接酶活性。 Sgt1在大肠和胃肿瘤中的高表达表明Sgt1参与了肿瘤的发生。在这里,我们报告Sgt1在结肠,乳腺和肺部肿瘤组织以及尤因肉瘤和横纹肌肉瘤异种移植物中过度表达。我们还发现,Sgt1杂合基因敲除可抑制体外Hras介导的转化,并在p53 ?/?小鼠胚胎成纤维细胞中形成肿瘤,并显着提高p53 ?/?老鼠。此外,Sgt1的消耗分别抑制了尤因肉瘤和横纹肌肉瘤细胞的生长以及细胞生长所必需的不稳定的EWS-FLI1和PAX3-FOXO1致癌融合蛋白。我们的结果表明,Sgt1通过稳定癌蛋白来促进癌症的发展,并且Sgt1是潜在的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号